A high expression of phosphorylated Akt (pAkt-1) is associated with a poorer recurrence-free survival in prostate cancer [31], and it would clearly be of interest to investigate whether the expression of CB1 receptors is correlated with pAkt-1 in prostate tumour tissue obtained at diagnosis. Here, AKT1 is linked to prostate cancer.